Nanjing Well Pharmaceutical GroupLtd Past Earnings Performance
Past criteria checks 4/6
Nanjing Well Pharmaceutical GroupLtd's earnings have been declining at an average annual rate of -2.4%, while the Chemicals industry saw earnings growing at 7.5% annually. Revenues have been growing at an average rate of 9.8% per year. Nanjing Well Pharmaceutical GroupLtd's return on equity is 8.3%, and it has net margins of 10.4%.
Key information
-2.4%
Earnings growth rate
-4.8%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 9.8% |
| Return on equity | 8.3% |
| Net Margin | 10.4% |
| Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How Nanjing Well Pharmaceutical GroupLtd makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1,321 | 138 | 120 | 62 |
| 31 Mar 24 | 1,239 | 120 | 123 | 58 |
| 31 Dec 23 | 1,156 | 112 | 122 | 56 |
| 30 Sep 23 | 1,089 | 95 | 90 | 57 |
| 30 Jun 23 | 1,046 | 88 | 107 | 54 |
| 31 Mar 23 | 1,067 | 94 | 108 | 56 |
| 31 Dec 22 | 1,111 | 95 | 122 | 54 |
| 30 Sep 22 | 1,129 | 96 | 142 | 43 |
| 30 Jun 22 | 1,146 | 106 | 134 | 45 |
| 31 Mar 22 | 1,105 | 103 | 124 | 42 |
| 31 Dec 21 | 1,042 | 101 | 110 | 41 |
| 30 Sep 21 | 989 | 109 | 73 | 45 |
| 30 Jun 21 | 889 | 99 | 79 | 39 |
| 31 Mar 21 | 808 | 94 | 76 | 37 |
| 31 Dec 20 | 736 | 100 | 74 | 35 |
| 30 Sep 20 | 732 | 93 | 103 | 34 |
| 30 Jun 20 | 775 | 109 | 91 | 35 |
| 31 Mar 20 | 823 | 122 | 89 | 33 |
| 31 Dec 19 | 881 | 128 | 92 | 32 |
| 30 Sep 19 | 862 | 138 | 82 | 29 |
| 30 Jun 19 | 832 | 127 | 78 | 24 |
| 31 Mar 19 | 822 | 123 | 78 | 25 |
| 31 Dec 18 | 801 | 112 | 74 | 24 |
| 30 Sep 18 | 779 | 109 | 53 | 40 |
| 30 Jun 18 | 771 | 108 | 62 | 35 |
| 31 Mar 18 | 720 | 104 | 66 | 28 |
| 31 Dec 17 | 694 | 107 | 66 | 22 |
| 31 Dec 16 | 558 | 85 | 87 | 0 |
| 31 Dec 15 | 499 | 61 | 61 | 0 |
| 31 Dec 14 | 528 | 45 | 57 | 0 |
Quality Earnings: 603351 has high quality earnings.
Growing Profit Margin: 603351's current net profit margins (10.4%) are higher than last year (8.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603351's earnings have declined by 2.4% per year over the past 5 years.
Accelerating Growth: 603351's earnings growth over the past year (57.1%) exceeds its 5-year average (-2.4% per year).
Earnings vs Industry: 603351 earnings growth over the past year (57.1%) exceeded the Chemicals industry -10.6%.
Return on Equity
High ROE: 603351's Return on Equity (8.3%) is considered low.